
Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit
Author(s) -
Holly Kinahan,
Abhishek Maiti,
Kenneth R. Hess,
Jennifer Dempsey,
Laura Beatty,
Sarah Baldwin,
David S. Hong,
Aung Naing,
Siqing Fu,
Apostolia M. Tsimberidou,
Sarina A. Piha-Paul,
Filip Janků,
Daniel D. Karp,
Suresh Reddy,
Sriram Yennurajalingam,
Daniel E. Epner,
Éduardo Bruera,
Funda MericBernstam,
Gerald S. Falchook,
Vivek Subbiah
Publication year - 2016
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000449505
Subject(s) - medicine , cancer , retrospective cohort study , clinical trial , cohort , oncology
Patients with advanced cancer who progress on standard therapy are potential candidates for phase I clinical trials. Due to their aggressive disease and complex comorbid conditions, these patients often need inpatient admission. This study assessed the outcomes of such patients after they were discharged to hospice care.